Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections
D Vassilopoulos, LH Calabrese - Current opinion in rheumatology, 2007 - journals.lww.com
Current opinion in rheumatology, 2007•journals.lww.com
Clinicians should be aware of the risk for viral reactivation of an underlying chronic viral
infection during immunosuppressive therapy. Despite the existence of such risk, the
presence of chronic viral infection is not a contraindication to immunosuppressive therapy,
given that appropriate pretherapy screening and close monitoring is applied.
infection during immunosuppressive therapy. Despite the existence of such risk, the
presence of chronic viral infection is not a contraindication to immunosuppressive therapy,
given that appropriate pretherapy screening and close monitoring is applied.
Summary
Clinicians should be aware of the risk for viral reactivation of an underlying chronic viral infection during immunosuppressive therapy. Despite the existence of such risk, the presence of chronic viral infection is not a contraindication to immunosuppressive therapy, given that appropriate pretherapy screening and close monitoring is applied.
Lippincott Williams & Wilkins